0002046372-24-000001.txt : 20241127 0002046372-24-000001.hdr.sgml : 20241127 20241127130454 ACCESSION NUMBER: 0002046372-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b ITEM INFORMATION: Investment Company Act Section 3(c) ITEM INFORMATION: Section 3(c)(1) FILED AS OF DATE: 20241127 DATE AS OF CHANGE: 20241127 EFFECTIVENESS DATE: 20241127 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alto Pharmacy Nov 2024 a Series of Warren Point Funds LLC CENTRAL INDEX KEY: 0002046372 ORGANIZATION NAME: IRS NUMBER: 331810292 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-530659 FILM NUMBER: 241509120 BUSINESS ADDRESS: STREET 1: 2093 PHILADELPHIA PIKE STREET 2: 5885 CITY: CLAYMONT STATE: DE ZIP: 19703 BUSINESS PHONE: (360) 946-0604 MAIL ADDRESS: STREET 1: 2093 PHILADELPHIA PIKE STREET 2: 5885 CITY: CLAYMONT STATE: DE ZIP: 19703 D 1 primary_doc.xml X0708 D LIVE 0002046372 Alto Pharmacy Nov 2024 a Series of Warren Point Funds LLC 2093 PHILADELPHIA PIKE 5885 CLAYMONT DE DELAWARE 19703 (360) 946-0604 DELAWARE None None Limited Liability Company true 2024 LLC Sydecar 2093 Philadelphia Pike #5885 Claymont DE DELAWARE 19703 Director Administrator of the Issuer Brett Sagan c/o Sydecar LLC 2093 Philadelphia Pike #5885 Claymont DE DELAWARE 19703 Executive Officer Officer of the Issuer's Administrator Pooled Investment Fund Venture Capital Fund false Decline to Disclose 06b 3C 3C.1 false 2024-11-19 false true false 0 1789952 1789952 0 false 15 0 0 12501 This amount represents a cost to cover fund organizational and operating expenses. false Alto Pharmacy Nov 2024 a Series of Warren Point Funds LLC /s/ Brett Sagan Brett Sagan General Manager of the Administrator 2024-11-27